Fundraising FoxRaytherapeutics
2 known investors
Find your way into Raytherapeutics
Sign up to see every warm intro you have to Raytherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Raytherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ray Therapeutics develops optogenetics gene therapy treatments for blinding diseases using advanced biotechnology. The company focuses on addressing unmet patient needs in ophthalmology through gene therapy innovation.
Founders & leadership
PB
Paul BresgeCo-founder & Chief Executive Officer
Investors · 2
Frequently asked questions
- What does Raytherapeutics do?
- Ray Therapeutics develops optogenetics gene therapy treatments for blinding diseases using advanced biotechnology. The company focuses on addressing unmet patient needs in ophthalmology through gene therapy innovation.
- Who founded Raytherapeutics?
- Raytherapeutics was founded by Paul Bresge.
- Who are Raytherapeutics's investors?
- Raytherapeutics's investors include Norwest Venture Partners, Novo Holdings.